Announced Mon, 27 Apr · 15:28 IST
Board to consider Final Dividend if any subject to approval of the Shareholders in forthcoming Annual General Meeting
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.7%1-day move
₹43.60
prior close
₹45.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+5.7+3.0+0.9-1.4-3.4-8.5-11.3+0.9-5.3-9.9
Up moveDown movePending
AI summary
Sandu Pharmaceuticals Ltd's board has announced it will consider recommending a final dividend at the forthcoming Annual General Meeting. The actual dividend amount, if any, remains unspecified in this filing. Any dividend recommended by the board will be subject to approval by shareholders at the AGM. This is a standard procedural announcement indicating dividend consideration is on the agenda.
Likely market impact
Positive signal for shareholders as the board is actively considering a dividend payout, though investors should wait for the actual dividend amount to be declared. No immediate price impact until specifics are known.